Unknown

Dataset Information

0

Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.


ABSTRACT: Endogenous and pharmacologic glucocorticoids (GCs) limit inflammatory cascades initiated by Toll-like receptor (TLR) activation. A long-standing clinical observation has been the delay between GC administration and the manifestation of GC's anti-inflammatory actions. We hypothesized that the GCs would have inhibitory effects that target late temporal pathways that propagate proinflammatory signals. Here we interrogated signal transducer and activator of transcription 1 (STAT1) regulation by GC and its consequences for cytokine production during activation of macrophages with TLR-specific ligands. We found that robust STAT1 activation does not occur until 2-3 h after TLR engagement, and that GC suppression of STAT1 phosphorylation first manifests at this time. GC attenuates TLR4-mediated STAT1 activation only through induction of suppressor of cytokine signaling 1 (SOCS1), which increases throughout the 6-h period after treatment. Inhibition of TLR3-mediated STAT1 activation occurs via two mechanisms, impairment of type I IFN secretion and induction of SOCS1. Our data show that SOCS1 and type I interferons are critical GC targets for regulating STAT1 activity and may account for overall GC effectiveness in inflammation suppression in the clinically relevant time frame.

SUBMITTER: Bhattacharyya S 

PROVIDER: S-EPMC3111275 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.

Bhattacharyya Sandip S   Zhao Yuxing Y   Kay Thomas W H TW   Muglia Louis J LJ  

Proceedings of the National Academy of Sciences of the United States of America 20110523 23


Endogenous and pharmacologic glucocorticoids (GCs) limit inflammatory cascades initiated by Toll-like receptor (TLR) activation. A long-standing clinical observation has been the delay between GC administration and the manifestation of GC's anti-inflammatory actions. We hypothesized that the GCs would have inhibitory effects that target late temporal pathways that propagate proinflammatory signals. Here we interrogated signal transducer and activator of transcription 1 (STAT1) regulation by GC a  ...[more]

Similar Datasets

| S-EPMC3769249 | biostudies-literature
| S-EPMC6125399 | biostudies-literature
| S-EPMC2973829 | biostudies-literature
| S-EPMC2211994 | biostudies-literature
| S-EPMC4263766 | biostudies-literature
| S-EPMC416411 | biostudies-other
| S-EPMC5095532 | biostudies-literature
| S-EPMC3382127 | biostudies-other
| S-EPMC3143647 | biostudies-literature
| S-EPMC6365456 | biostudies-literature